Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma

The expression levels of CTLA-4 and CD28 were analyzed in 191 nasopharyngeal carcinoma (NPC) patients diagnosed and treated at our hospital between January 2010 and November 2011. The 3-year overall survival (OS) rate (91.4% vs. 81.2%,p = 0.043), failure-free survival (FFS) rate (82.8% vs. 68.0%, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Pei-Yu, Guo, Shan-Shan, Zhang, Yu, Lu, Jia-Bin, Chen, Qiu-Yan, Tang, Lin-Quan, Zhang, Lu, Liu, Li-Ting, Zhang, Li, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914341/
https://www.ncbi.nlm.nih.gov/pubmed/26918337
http://dx.doi.org/10.18632/oncotarget.7421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914341/
https://www.ncbi.nlm.nih.gov/pubmed/26918337
http://dx.doi.org/10.18632/oncotarget.7421

Ejemplares similares